2021
DOI: 10.23736/s2532-1285.21.00044-6
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 and hemorrhagic complications: pectoral hematoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 15 publications
2
3
0
Order By: Relevance
“…8,13,26,32,34 Dohan and colleagues argued that the presence of active bleeding is related to a greater severity of the clinical picture. 32 As in some cases in our study, Benazzi et al reported pulmonary embolism in one of their two cases, 17 Dennison et al reported the case of a patient with splenic ischaemia, abdominal wall haemorrhage and mesenteric vessel infarction, 13 while concomitance of DVT and haemorrhage has been reported by other authors.…”
Section: Symptoms and Imagingsupporting
confidence: 75%
See 2 more Smart Citations
“…8,13,26,32,34 Dohan and colleagues argued that the presence of active bleeding is related to a greater severity of the clinical picture. 32 As in some cases in our study, Benazzi et al reported pulmonary embolism in one of their two cases, 17 Dennison et al reported the case of a patient with splenic ischaemia, abdominal wall haemorrhage and mesenteric vessel infarction, 13 while concomitance of DVT and haemorrhage has been reported by other authors.…”
Section: Symptoms and Imagingsupporting
confidence: 75%
“…14,18 Among the risk factors for the development of bleeding in COVID-19 patients, contributing causes have been proposed, such as pronation manoeuvres, anticoagulant treatment, obesity, increased vascular fragility determined by the proinflammatory state, barotrauma from ventilation by C-PAP and cough with consequent increase in intra-abdominal pressure and arterial rupture. 17,19 Many of these risk factors coincide with those that have been documented in this article.…”
Section: Role Of Anticoagulation In Covid-19 Therapy and Risk Factors...supporting
confidence: 68%
See 1 more Smart Citation
“…In critically ill patients, a higher incidence of disseminated intravascular coagulopathy, and/hemorrhagic complications have been reported [8,10,24,25]. Even rare cases with subcutaneous hematomas developed during the acute phase of the disease, related mostly to the administration of anticoagulants have been described [11,17,[26][27][28]. While thrombotic events occurred early, in the first week of the acute illness, it was observed that hematomas appeared after 2-3 weeks, mostly in elderly people with comorbidities [27,28].…”
Section: Discussionmentioning
confidence: 99%
“…We have already described two of these clinical cases in our previous publication. 15 In this new article, we describe a third similar case: she was obese as the other two women, and she had a pectoral hematoma, a problem that was very rare before this pandemic. We have also reviewed clinical reports from 2020 to 2022 about hemorrhagic complications during COVID-19 (PubMed and online reviewed publications).…”
Section: Introductionmentioning
confidence: 92%